Sale!

ROS 1 NSCLC Genetic Testing

Original price was: $350.Current price is: $262.

-25%

ROS 1 NSCLC genetic testing is a specialized molecular diagnostic procedure that identifies ROS 1 gene rearrangements in non-small cell lung cancer patients. This advanced FISH (Fluorescence In Situ Hybridization) test analyzes tumor tissue samples to detect specific genetic alterations that can guide targeted therapy decisions. The test is crucial for patients diagnosed with NSCLC to determine eligibility for ROS 1 inhibitor treatments, which can significantly improve treatment outcomes and quality of life. With results available in 7-8 days and a discounted price of $262 USD (regularly $350 USD), this test provides valuable insights for personalized cancer care. Early detection of ROS 1 rearrangements enables oncologists to implement precision medicine approaches, potentially leading to better response rates and fewer side effects compared to traditional chemotherapy.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ROS 1 NSCLC Genetic Testing: Comprehensive Biomarker Analysis

Understanding ROS 1 NSCLC Genetic Testing

ROS 1 NSCLC genetic testing represents a breakthrough in precision oncology, specifically designed to identify ROS 1 gene rearrangements in patients diagnosed with non-small cell lung cancer (NSCLC). This sophisticated molecular diagnostic test plays a critical role in modern cancer care by enabling targeted treatment strategies that can significantly improve patient outcomes and quality of life.

What Does the Test Measure?

The ROS 1 NSCLC test utilizes advanced FISH (Fluorescence In Situ Hybridization) technology to detect specific genetic rearrangements involving the ROS 1 gene. These rearrangements create fusion proteins that drive cancer growth and progression. The test analyzes:

  • ROS 1 gene fusion events
  • Chromosomal rearrangements in tumor tissue
  • Biomarker status for targeted therapy eligibility
  • Genetic alterations that respond to specific inhibitor treatments

Who Should Consider ROS 1 NSCLC Testing?

This test is particularly important for individuals who:

  • Have been diagnosed with non-small cell lung cancer
  • Are experiencing persistent respiratory symptoms
  • Have a history of smoking or environmental exposure
  • Need to determine eligibility for targeted therapies
  • Seek personalized treatment options beyond standard chemotherapy
  • Want to understand their cancer’s genetic profile

Clinical Indications and Symptoms

Patients presenting with symptoms such as persistent cough, chest pain, shortness of breath, unexplained weight loss, or recurrent respiratory infections should discuss ROS 1 testing with their oncologist. Early genetic profiling can significantly impact treatment decisions and outcomes.

Benefits of ROS 1 NSCLC Genetic Testing

Undergoing ROS 1 genetic testing offers numerous advantages:

  • Personalized Treatment Planning: Identifies patients who may benefit from ROS 1 inhibitor therapies
  • Improved Response Rates: Targeted therapies often show better efficacy than traditional treatments
  • Reduced Side Effects: Precision medicine approaches typically have fewer adverse effects
  • Informed Decision Making: Provides crucial information for treatment strategy development
  • Comprehensive Cancer Profiling: Contributes to a complete understanding of your cancer’s genetic makeup

Understanding Your Test Results

Your ROS 1 NSCLC test results will fall into one of two categories:

Positive Result

A positive result indicates the presence of ROS 1 gene rearrangement, making you a candidate for targeted therapy with ROS 1 inhibitors. This finding opens the door to potentially more effective treatment options with improved quality of life during therapy.

Negative Result

A negative result means no ROS 1 rearrangement was detected. While this excludes ROS 1 targeted therapy as an option, it helps your medical team focus on other potential treatment strategies and continue comprehensive biomarker testing.

Test Details and Pricing

Test Parameter Details
Test Name ROS 1 NSCLC Genetic Testing
Regular Price $350 USD
Discount Price $262 USD
Turnaround Time 7-8 Days
Sample Type Tumor Tissue
Test Components Paraffin Embedded Tissue Blocks
Testing Method FISH (Fluorescence In Situ Hybridization)

Pre-Test Instructions

ROS 1 NSCLC testing requires a doctor’s prescription for most cases. Please note that prescriptions are not applicable for surgical procedures, pregnancy cases, or individuals planning international travel. Consult with your healthcare provider to determine if this test is appropriate for your specific situation.

Nationwide Testing Availability

We have diagnostic branches conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible, high-quality genetic testing services for patients throughout the country.

Take Control of Your Cancer Journey

Understanding your cancer’s genetic profile is the first step toward personalized treatment. ROS 1 NSCLC testing provides critical information that can transform your treatment approach and potentially improve outcomes. Don’t leave your treatment decisions to chance – get the comprehensive genetic information you need to make informed choices about your care.

Ready to Schedule Your Test?

Take the next step in your cancer care journey. Contact our genetic specialists today to schedule your ROS 1 NSCLC testing or to learn more about how genetic profiling can benefit your treatment plan.

Call or WhatsApp: +1(267) 388-9828

Our dedicated team is available to answer your questions, discuss testing options, and help you schedule your appointment at a location convenient for you.